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AbSlIWt 
Saposin B is a lysosomal sphingolipid-activator-protein which activates GMl-ganglioside hydrolysis by lysosomalb-galactosidase. To identify the 
structural elements of saposin B implicated in sphingolipid binding, we studied a synthetic peptide corresponding to a predicted a-helix, sapB-18, 
spanning residues 52 to 69 of saposin B. The circular dichroism spectrum of sapB-18 at pH 4.4 was consistent with a 44% a-helix content. As shown 
by intrinsic Tyr fluorescence studies of sapB-18, this peptide binds the GMl-ganglioside with a & of about 7 PM. Thus, we suggest hat a putative 
amphipathic a-helix between residues 52 and 69 of saposin B plays a major role in the recognition and binding of GMl-ganglioside by saposin B. 
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1. Introductloll 
The four saposins are small dimeric glycoproteins, 
with subunit M, of S-10 kDa, which activate the hydrol- 
ysis of sphingolipids by lysosomal hydrolases [1,2]. They 
have a common precursor, prosaposin, of M, 70 kDa [3] 
containing the saposins as four repeated domains A, B, 
C and D [4-7]. Saposins A and C are /I-glucosidase acti- 
vator proteins [6,8], saposin B, also named the sphingo- 
lipid-activator-protein, is the activator of arylsulfatase 
A, /I-galactosidase, a-galactosidase [4] and neuram- 
inidase [9]; and saposin D is a sphingomyelinase activa- 
tor protein [lo]. The physiological function of saposin B 
is apparently to bring together sphingolipids and lyso- 
somal enzymes for efficient hydrolysis of hydrophobic 
lipid substrates [l 11. Both saposin B and prosaposin bind 
a variety of sphingolipids and were proposed to be ac- 
tively involved in intracellular lipid transport [ 12-161. 
The deficiency of saposin B causes a lysosomal storage 
disease with a clinical presentation similar to that of 
metachromatic leukodystrophy [ 17) The deficiency of 
saposin C was described in a single patient with a variant 
form of Gaucher disease [18]. No speci8c deficiency of 
saposin A and D have yet been described but two pa- 
tients with prosaposin deficiency due to a mutation in the 
initiation codon of the prosaposin gene have been re- 
ported [19]. 
The structure of prosaposin and the saposins are still 
unknown but, in a previous paper, we proposed a struc- 
tural model of saposin B containing an amphipathic 
a-helix between residues 56 and 65 [20]. In the present 
paper, we use circular dichroism spectroscopy to confirm 
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the helical conformation in solution of a synthetic pep- 
tide, sapB-18, including this region of saposin B. Because 
some amphipathic +helices have been implicated in pro- 
tein-lipid interactions [21-231, we analyzed the capacity 
of sapB-18 to bind to GMl-ganglioside. 
2. Materials and methods 
2.1. Materials 
The peptide sapB-18, NH,-Ser-Gln-Tyr-Ser-Glu-Ile-Ala-Ile-Gln- 
Met-Met-Met-His-Met-Gln-Pro-Lys-Glu-NH,, corresponding to the 
residues Se? to Glu@ of saposin B was purchased from Multiple 
Peptide Systems, San Diego, CA. It was purified by reverse phase 
HPLC and analyzed by fast-atom-bombardment-mass spectrometry. 
The mass of sapB-18 was 2182 Da, within 1 Da of the mass of the 
peptide computed from monoisotopic elemental composition. The 
GMl-ganglioside was purchased from Calbiochem, San Diego, CA. 
2.2. Circular dichroism spectroscopy 
The peptide sapB-18 (91.7 PM in 0.2 M sodium acetate buffer, pH 
4.4) was analyzed by circular dichroism spectroscopy at room temper- 
ature in a Jobin Yvon model CD6 spectrophotometer. The percentage 
of a-helix was computed from the spectrum according to a curve-fitting 
software developed in the Department of Biochemistry, University of 
Cambridge. 
The amphipathic haracter of the putative a-helix (residues 56 to 65) 
of saposin B was determined by computing its mean hydrophobicity per 
residue, <H>, and hydrophobic moment, ep>, according to the 
method of Eisenberg et al. [21]. 
2.3. Fluorescence measurements 
The measurement of intrinsic Ty? fluorescence of the sapB-18 pep- 
tide was used to study GMl-ganglioside binding in a Perkin-Elmer 
model LS 30 spectrofluorometer atan excitation wavelength of 280 mn. 
The fluorescence spectrum of 5 PM sapB-18 was recorded in the pres- 
ence of increasing concentrations of GMl-ganglioside between 0.625 
and 12.5pM. The spectra were corrected for the fluorescence associated 
to GMl-ganglioside itself. The GMl-ganglioside was dissolved in chlo- 
roform/methanol 2:1 and the solvent was evaporated under a stream 
of nitrogen. The lipid was resuspended in 0.2 M sodium acetate buffer, 
pH 4.4, and sonicated for 6 s with an ARTEK sonicator at 60% of 
maximum intensity. The peptide-lipid mixture was incubated for 10 
min at 20°C before recording the fluorescence spectrum. 
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The lipid-peptide interaction was analyzed by means of a Scatchard 
plot to determine the number of lipid (L) binding sites per mole of 
peptide (P), n, and the equilibrium dissociation constant, &, of the 
complex. 
P+L PL 
Y-=II+? 
V-1 Kd K, 
(1) 
(2) 
(3) 
Z, is the fluorescence intensity of the free peptide and IL is the fluores- 
cence intensity of peptide in presence of GMl-ganglioside ligand. 
3. Results and discussion 
The predicted a-helix of saposin B (between residues 
Gl#’ and Met65) is an amphipathic helix with a mean 
hydrophobicity per residue <H> of 0.40 and a hydro- 
phobic moment <run> of 0.28. It has an amphipatic har- 
acter between that of a transmembrane and a globular 
protein a-helix in the classification of Eisenberg et al. 
[21]. Thus, this putative a-helix is a good candidate sub- 
domain of saposin B for interaction with sphingolipids. 
Saposin B binds to the GMl-ganglioside [4,11]. We 
have hypothesized that the putative amphipathic a-helix 
between residues 56 and 65 of saposin B may be im- 
plicated in this binding function [20]. To test this hypo- 
thesis, the peptide sapB-18, NH,-Ser-Gln-Tyr-Ser-Glu- 
Ile-Ala-Ile-Gln-Met-Met-Met-His-Met-Gln-Pro-Lys-Glu- 
NH2 corresponding to the sequence Ser” to G1u’j9 of 
saposin B was synthesized. The circular dichroism spec- 
trum of sapB- 18 is compatible with a 44% a-helix content 
with typical minima at 208 and 220 nm (Fig. 1). How- 
ever, it must be pointed out that in the complete saposin 
B structure, this peptide may adopt a different conforma- 
tion. 
The peptide-lipid interaction was studied by measur- 
ing Tyr3 fluorescence of the sapB-18 peptide as a func- 
tion of increasing GM 1 -ganglioside concentration. De- 
termination of the binding constant using a Scatchard 
plot according to Equation (2) yielded a Kd value of 
7.0 f 2.1 ,uM and an n value of 0.82 + 0.25 (mean + S.D. 
of 3 determinations) (Fig. 2). This result suggests that 
there is only one GMl-ganglioside binding site per 
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Fig. 1. Circular dichroism spectrum of the synthetic peptide sapB-18. 
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Fig. 2. Scatchard analysis of GMl-ganglioside-binding to the synthetic 
peptide sapB- 18. 
sapB-18 peptide molecule. The binding constant of 
GM 1 -ganglioside for sapB- 18 is close to that determined 
for purified saposin B (around 12 PM) by Hiraiwa et al. 
[15]. This result suggests that the sapB-18 peptide plays 
a role in sphingolipid binding and recognition but does 
not exclude the participation of other structural elements 
of saposin B. As a control experiment, an 18-residue 
synthetic peptide derived from the same region of 
saposin C, as sapB- 18 was derived from saposin B (Fig. 
3), did not bind the GMl-ganglioside (data not shown). 
Patthy reported that saposin B is similar to the surfac- 
tant protein B (SP-B), another lipid-binding protein [22]. 
This protein is a major component of the lung surfactant 
together with other lipid-binding proteins and phospho- 
lipids. It is interesting to note that a synthetic peptide 
(Leu49 to Leu& of SP-B), corresponding approximately 
to the position of sapB-18 in saposin B, also adopts an 
a-helical conformation and binds lipids [23]. This simi- 
larity between SP-B and saposin B suggests that these 
two similar proteins may bind lipids using similar struc- 
tural elements and mechanisms. 
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B CKNYISOYSEIA - - ICALVGFCDEVXBM 
C CQswpTXESSUSIWjEEvs-~VCsMLHLCSGTRLp 
D CDQFVAEYEPVLIEILVEW&DPSFVCLKIGACPSASiKP 
Fig. 3. Alignment of saposins A, B, C and D ammo acid sequences [4] 
indicating the synthetic peptides sapB-18 and sapC-18 sequences. 
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